PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,184 | -15.6% | 122,892 | +13.3% | 0.01% | -20.0% |
| Q2 2023 | $382,801 | +23.8% | 108,448 | +8.4% | 0.02% | +15.4% |
| Q1 2023 | $309,204 | -17.2% | 100,072 | +13.3% | 0.01% | -31.6% |
| Q4 2022 | $373,602 | +91.6% | 88,322 | +7.4% | 0.02% | +90.0% |
| Q3 2022 | $195,000 | -6.7% | 82,247 | +12.0% | 0.01% | -9.1% |
| Q2 2022 | $209,000 | +21.5% | 73,424 | +23.0% | 0.01% | +57.1% |
| Q1 2022 | $172,000 | +56.4% | 59,680 | +65.6% | 0.01% | +40.0% |
| Q4 2021 | $110,000 | -55.6% | 36,032 | +1.9% | 0.01% | -58.3% |
| Q3 2021 | $248,000 | +5.1% | 35,360 | +37.3% | 0.01% | 0.0% |
| Q2 2021 | $236,000 | +11.3% | 25,745 | +18.3% | 0.01% | -7.7% |
| Q1 2021 | $212,000 | +9.8% | 21,768 | +15.6% | 0.01% | 0.0% |
| Q4 2020 | $193,000 | +52.0% | 18,828 | +54.5% | 0.01% | +18.2% |
| Q2 2020 | $127,000 | – | 12,186 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |